, Tracking Stock Market Picks
Enter Symbol:
Pain Therapeutics (PTIE) [hlAlert]

down 78.36 %

Pain Therapeutics (PTIE) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Jun 5, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Pain Therapeutics (NASDAQ: PTIE) on 06/05/2008, when the stock price was $8.09. Since
then, Pain Therapeutics has lost 78.37% as of 09/25/2015's recent price of $1.75.
If you would have followed this Merriman Curhan Ford's recommendation on PTIE, you would have lost 78.36% of your investment in 2668 days.

Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief, fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/5/2008 8:25 AM Buy
as of 12/24/2008
1 Week up  2.07 %
1 Month up  4.23 %
3 Months down  -29.00 %
1 YTD down  -25.16 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy